therapy-specific side effects of aromatase inhibi-

publicité

publicité

Documents connexes

NEWS IN BRIEF Neratinib Graduates to I-SPY 3

NEWS IN BRIEF Neratinib Graduates to I-SPY 3

Robert Vanden Eynde

Robert Vanden Eynde

patritumab selected for I-SPY 2 TRIAL in breast cancer.docx

patritumab selected for I-SPY 2 TRIAL in breast cancer.docx

PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib

PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib

I-SPY 2 — Toward More Rapid Progress in Breast Cancer Treatment

I-SPY 2 — Toward More Rapid Progress in Breast Cancer Treatment

2015/2016 Marketing Models Use of languages Contact

2015/2016 Marketing Models Use of languages Contact

Poulakidas Angela

Poulakidas Angela

PREVENTION OF SYMPTOMATIC WITH – A NONINFERIORITY

PREVENTION OF SYMPTOMATIC WITH – A NONINFERIORITY

2015/2016 Marketing Use of languages Contact

2015/2016 Marketing Use of languages Contact

I-SPY 2 Shows Efficacy of T-DM1-Pertuzumab.docx

I-SPY 2 Shows Efficacy of T-DM1-Pertuzumab.docx

Table of Contents

Table of Contents

Seminars 2016 – 2017 Every first Monday of the month at 16h15

Seminars 2016 – 2017 Every first Monday of the month at 16h15